Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Tuesday (RX)

Automated Summaries - The Globe and Mail - Tue Apr 9, 4:02PM CDT

Today, shares of Biosyent Inc opened at $8.56 and closed at $8.60. prices ranged from a low of $8.56 to a high of $8.65.

The price eased -0.58% from the previous day's close of $8.65.

During the day across North America, the TSX Composite closed -0.02% at 22260.30, the S&P 500 closed -0.04% at 5202.39, the Dow Jones Industrial Average closed -0.03% at 38892.80 and the Nasdaq Composite closed 0.03% at 16253.96.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 42,453 on 14 total trades, while having an average volume of 11,509 over the last 5-days.

The TSX-V overall saw 2,909 price advancers against 2,322 declines and 125 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have advanced 13.31%, while this year, they have decreased -6.72%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.48 million on a float of 11,616 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 1.00 analysts, Biosyent Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe